$OGEN
ORAGENICS INC

2016 Q1 Form 10-K Financial Statement

#000119312516523810 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q3
Revenue $0.00 $240.2K $329.8K
YoY Change -100.0% 8.95% 64.07%
Cost Of Revenue $89.95K $0.00 $0.00
YoY Change -46.45% -100.0% -100.0%
Gross Profit $172.3K $0.00 $0.00
YoY Change -11.99% -100.0% -100.0%
Gross Profit Margin 0.0% 0.0%
Selling, General & Admin $994.4K $850.0K $853.9K
YoY Change 21.95% 4.94% 51.11%
% of Gross Profit 577.13%
Research & Development $1.225M $1.340M $1.104M
YoY Change 81.02% 143.64% 84.92%
% of Gross Profit 710.84%
Depreciation & Amortization $20.00K $20.00K $20.00K
YoY Change 100.0% 100.0% 100.0%
% of Gross Profit 11.61%
Operating Expenses $2.075M $2.196M $1.866M
YoY Change 50.9% 61.44% 60.56%
Operating Profit -$2.075M -$2.196M -$1.866M
YoY Change 60.05% 78.5% 80.31%
Interest Expense $771.00 -$20.00K $39.56K
YoY Change 27.23% -300.0% 2931.72%
% of Operating Profit
Other Income/Expense, Net $647.00 $0.00 -$34.16K
YoY Change -81.55% -743.92%
Pretax Income -$2.074M -$2.220M -$1.900M
YoY Change 60.43% 81.97% 84.56%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.063M -$2.219M -$1.864M
YoY Change 59.57% 81.39% 81.02%
Net Earnings / Revenue -923.85% -565.1%
Basic Earnings Per Share
Diluted Earnings Per Share -$515.0K -$590.4K -$511.0K
COMMON SHARES
Basic Shares Outstanding 40.06M shares 36.48M shares 36.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.370M $5.080M $6.740M
YoY Change -62.76% -51.39% -42.69%
Cash & Equivalents $3.368M $5.083M $6.739M
Short-Term Investments
Other Short-Term Assets $190.0K $210.0K $170.0K
YoY Change 46.15% 75.0% -22.73%
Inventory $241.5K $321.5K $299.3K
Prepaid Expenses
Receivables $32.75K $21.12K $19.37K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.835M $5.638M $7.231M
YoY Change -60.03% -48.86% -41.1%
LONG-TERM ASSETS
Property, Plant & Equipment $122.4K $140.7K $159.3K
YoY Change -27.02% 28.69% 505.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $122.4K $140.7K $159.3K
YoY Change -27.02% 28.69% 505.65%
TOTAL ASSETS
Total Short-Term Assets $3.835M $5.638M $7.231M
Total Long-Term Assets $122.4K $140.7K $159.3K
Total Assets $3.957M $5.778M $7.390M
YoY Change -59.46% -48.09% -39.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $990.0K $970.0K $760.0K
YoY Change 94.12% 36.62% 26.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $80.00K $60.00K $5.110M
YoY Change 0.0% 0.0% 4545.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.083M $1.047M $5.887M
YoY Change 78.76% 31.53% 696.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.083M $1.047M $5.887M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.080M $1.050M $5.890M
YoY Change 77.05% 31.25% 695.95%
SHAREHOLDERS EQUITY
Retained Earnings -$89.72M -$87.66M -$85.44M
YoY Change 16.16% 15.42% 14.34%
Common Stock $92.59M $92.39M $86.94M
YoY Change 7.18% 7.08% 0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.874M $4.731M $1.503M
YoY Change
Total Liabilities & Shareholders Equity $3.957M $5.778M $7.390M
YoY Change -59.46% -48.09% -39.93%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$2.063M -$2.219M -$1.864M
YoY Change 59.57% 81.39% 81.02%
Depreciation, Depletion And Amortization $20.00K $20.00K $20.00K
YoY Change 100.0% 100.0% 100.0%
Cash From Operating Activities -$1.620M -$1.600M -$1.270M
YoY Change 25.57% 35.59% 15.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$10.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.95K -50.00K -30.00K
YoY Change 13.16% 0.0% 0.0%
NET CHANGE
Cash From Operating Activities -1.620M -1.600M -1.270M
Cash From Investing Activities 0.000 -10.00K
Cash From Financing Activities -33.95K -50.00K -30.00K
Net Change In Cash -1.654M -1.650M -1.310M
YoY Change 18.97% 25.0% 15.93%
FREE CASH FLOW
Cash From Operating Activities -$1.620M -$1.600M -$1.270M
Capital Expenditures $0.00 -$10.00K
Free Cash Flow -$1.600M -$1.260M
YoY Change 46.79% 14.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40058540 shares
CY2009Q2 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
417000
CY2015Q2 dei Entity Public Float
EntityPublicFloat
20006925
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
633840 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.88
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
15838635
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1241781
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16276510
CY2013Q4 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
3540000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
820865 shares
CY2014Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.03
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36178944 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36178944 shares
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
50184
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
86244604
CY2014Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
64840
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2618
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Interest
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest
134222
CY2014Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
780
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10336148
CY2014Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
25500
CY2014Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
483641
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
102258
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
710210
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1354652
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
77776
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21222
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75944635
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11132420
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
36179
CY2014Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
12637
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1557027
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
796272
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26927920
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
4755
CY2014Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
10198921
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
368910
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26440553
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26927920
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
513106
CY2014Q4 us-gaap Assets
Assets
11132420
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
29267
CY2014Q4 us-gaap Inventory Net
InventoryNet
439189
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15608
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109292
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Assets Current
AssetsCurrent
11023128
CY2014Q4 us-gaap Inventory Gross
InventoryGross
489373
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
432
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
18885
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
113553
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
119410
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10448921
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
9596
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1666319
CY2014Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
6910
CY2014Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
5000
CY2014Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
42590
CY2014Q4 ogen Deferred Tax Assets Tax Deferred Expense Uniform Capitalization
DeferredTaxAssetsTaxDeferredExpenseUniformCapitalization
2958
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1471031 shares
CY2015Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.00
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39858540 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
651507 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
610047 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
175584 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2122538 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39858540 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.89
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
60660
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
221348
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
92347134
CY2015Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
63352
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3033
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
144854
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Interest
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest
134222
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
631129
CY2015Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
302107
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4731025
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
0
CY2015Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
25500
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
383888
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
155506
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
969787
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1708466
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
87624
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14215
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87655968
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5778379
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
39859
CY2015Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
11129
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
126520
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1447913
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1047354
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31199403
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
138407
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
222785
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30701734
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
563222
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31199403
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
513106
CY2015Q4 us-gaap Assets
Assets
5778379
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
33896
CY2015Q4 us-gaap Inventory Net
InventoryNet
321509
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21115
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
140651
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5637728
CY2015Q4 us-gaap Inventory Gross
InventoryGross
382169
CY2015Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4833355
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
4188
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
530
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
81059000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
22827
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
153461
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
211749
CY2015Q4 ogen Deferred Tax Assets Tax Deferred Expense Uniform Capitalization
DeferredTaxAssetsTaxDeferredExpenseUniformCapitalization
5158
CY2015Q1 ogen Class Of Warrant Expired
ClassOfWarrantExpired
2170925 shares
CY2015Q1 ogen Class Of Warrant Expired Weighted Average Exercise Price
ClassOfWarrantExpiredWeightedAverageExercisePrice
2.00
CY2014Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
135000 shares
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5083355
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
9596
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1588564
CY2015Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
5923
CY2015Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
1000
CY2015Q4 ogen Share Based Compensation Arrangement By Share Based Payment Award Shares Issued To Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedToDate
1877462 shares
CY2015Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
42590
CY2014Q1 ogen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
210000 shares
CY2015Q4 ogen Number Of Common Stock Outstanding If Warrants And Stock Options Exercised
NumberOfCommonStockOutstandingIfWarrantsAndStockOptionsExercised
41505155 shares
CY2009Q2 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50 pure
CY2013 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50 pure
CY2013 ogen Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
14900000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5559130
CY2014 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0 shares
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
70475 shares
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.93
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.55 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.65
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
257500 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0226 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0277 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.50 pure
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36153588 shares
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
110673
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-5789519
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
939926
CY2014 us-gaap Interest Paid
InterestPaid
4058
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
102500
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-214831
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
257007
CY2014 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
158999
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-5816495
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
150806
CY2014 us-gaap Gross Profit
GrossProfit
570329
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-203
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26976
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2052871
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-48826
CY2014 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
184532
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-203
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5789519
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
36998
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
112871
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
184532
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
34488
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2383
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
110518
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
15208
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5827589
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2052871
CY2014 us-gaap Operating Expenses
OperatingExpenses
6386824
CY2014 us-gaap Interest Expense
InterestExpense
4030
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-110249
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-158210
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3065053
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2052871
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
424
CY2014 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
61085
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5789
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-199747
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
102500
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1968437
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3321771
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
369597
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27667
CY2014 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-158210
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-210160
CY2014 ogen Common Stock Issued During Period Par Value For Warrants Exercise
CommonStockIssuedDuringPeriodParValueForWarrantsExercise
135
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5104385
CY2015 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0 shares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
278334 shares
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001174940
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.71
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Guaranteed Rights of Return</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The Company has granted guaranteed rights of return to two dental distributor customer accounts. The Company defers recognition of revenue on these accounts until the customer provides notification to the Company that the product has been sold to the end consumer or the guaranteed right of return period expires. Once notification has been received and verified, the Company records revenue in that accounting period. The Company had $14,215 and $21,222 of revenue deferred under guaranteed rights of return arrangements included in deferred revenue in the balance sheets as of December&#xA0;31, 2015 and 2014, respectively.</p> </div>
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentrations</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company is dependent on four key suppliers to provide probiotics, blending, warehousing and packaging of its EvoraPlus, EvoraPro, and Teddy&#x2019;s Pride products during the years ended December&#xA0;31, 2015 and 2014, respectively. The majority of the Company&#x2019;s cost of sales are from these key suppliers. As of December&#xA0;31, 2015 and 2014, our accounts payable and accrued expenses for these vendors totaled $91,138 and $189,120, respectively.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains cash accounts in commercial banks, which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. As of December&#xA0;31, 2015, the uninsured portion of this balance was $4,833,355. As of December&#xA0;31, 2014, the uninsured portion of this balance was $10,198,921.</p> </div>
CY2015 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03 pure
CY2015 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2035-12-31
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.49 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.31
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Registrant Name
EntityRegistrantName
ORAGENICS INC
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
928500 shares
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0214 pure
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0227 pure
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are anticipated milestone payments, stock based compensation, valuation of warrants, income tax valuation allowance, inventory obsolescence reserve, sales returns and allowances and allowance for doubtful accounts.</p> </div>
CY2015 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
Less than a 50%
CY2015 dei Trading Symbol
TradingSymbol
OGEN
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.47 pure
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36656257 shares
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102511
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-11711333
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
1175841
CY2015 us-gaap Interest Paid
InterestPaid
5241
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5071506
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66123
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
325361
CY2015 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
158462
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-11652119
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-117680
CY2015 us-gaap Gross Profit
GrossProfit
694098
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
776
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59214
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4271483
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5071506
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5507
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
770704
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1280
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
264000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11711333
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
21378
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
353814
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
770704
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
24634
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7007
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
288055
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-152564
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5365566
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4271483
CY2015 us-gaap Operating Expenses
OperatingExpenses
12346217
CY2015 us-gaap Interest Expense
InterestExpense
76668
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-101231
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-159950
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8803033
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4271483
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1280
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
35887
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4700
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
331083
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
264000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3981853
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3543184
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
481743
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
71152
CY2015 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-159950
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-425121
CY2015 ogen Cash And Cash Equivalents Maturity Date Description
CashAndCashEquivalentsMaturityDateDescription
Three months or less
CY2015 ogen Common Stock Issued During Period Par Value For Warrants Exercise
CommonStockIssuedDuringPeriodParValueForWarrantsExercise
99
CY2015 ogen Number Of Dental Distributor With Guaranteed Rights Of Returns
NumberOfDentalDistributorWithGuaranteedRightsOfReturns
2 Customer
CY2015 ogen Technology Access Fee Paid In Convertible Note Payable To Shareholder
TechnologyAccessFeePaidInConvertibleNotePayableToShareholder
5000000
CY2015 ogen Par Value Of Restricted Shares Issued
ParValueOfRestrictedSharesIssued
200
CY2012 ogen Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
13000000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1640884
CY2014Q1 us-gaap Revenues
Revenues
214660
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1783858
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1292777
CY2015Q1 us-gaap Revenues
Revenues
363774
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1492060
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2080663
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1895519
CY2014Q2 us-gaap Revenues
Revenues
303752
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6335471
CY2015Q2 us-gaap Revenues
Revenues
242038
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
6485551
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-1029544
CY2014Q3 us-gaap Revenues
Revenues
201010
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
1162148
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1863676
CY2015Q3 us-gaap Revenues
Revenues
329795
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
2024720
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-1223572
CY2014Q4 us-gaap Revenues
Revenues
220504
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
1360155
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2219409
CY2015Q4 us-gaap Revenues
Revenues
240234
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
2343886

Files In Submission

Name View Source Status
0001193125-16-523810-index-headers.html Edgar Link pending
0001193125-16-523810-index.html Edgar Link pending
0001193125-16-523810.txt Edgar Link pending
0001193125-16-523810-xbrl.zip Edgar Link pending
d52763d10k.htm Edgar Link pending
d52763dex231.htm Edgar Link pending
d52763dex311.htm Edgar Link pending
d52763dex312.htm Edgar Link pending
d52763dex321.htm Edgar Link pending
d52763dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ogen-20151231.xml Edgar Link completed
ogen-20151231.xsd Edgar Link pending
ogen-20151231_cal.xml Edgar Link unprocessable
ogen-20151231_def.xml Edgar Link unprocessable
ogen-20151231_lab.xml Edgar Link unprocessable
ogen-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending